National Health (Weighted average disclosed price – October 2019 reduction day) Amendment Determination 2019
National Health Act 1953
I, ADRIANA PLATONA, First Assistant Secretary, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 99ADB(4) of the National Health Act 1953.
Dated: 15 August 2019
ADRIANA PLATONA
First Assistant Secretary
Technology Assessment and Access Division
Department of Health
1 Name of Instrument
(1) This instrument is the National Health (Weighted average disclosed price – October 2019 reduction day) Amendment Determination 2019.
(2) This instrument may also be cited as PB 75 of 2019.
2 Commencement
This instrument commences on the day after it is registered.
3 Amendments to PB 45 of 2019
This instrument amends the National Health (Weighted average disclosed price – October 2019 reduction day) Determination 2019 (PB 45 of 2019).
Schedule 1 Amendments
[1] Schedule 1
omit:
5 | Bivalirudin | Powder for I.V. injection 250 mg (as trifluoroacetate) | Injection | Angiomax | 417.93 |
6 | Bivalirudin | Powder for I.V. injection 250 mg (as trifluoroacetate) | Injection | Bivalirudin APOTEX | 417.93 |
[2] Schedule 1
omit:
44 | Epirubicin | Solution for injection containing epirubicin hydrochloride 100 mg in 50 mL | Injection/Intravesical | Epirubicin ACT | 18.07 |
45 | Epirubicin | Solution for injection containing epirubicin hydrochloride 200 mg in 100 mL | Injection/Intravesical | Epirube | 36.14 |
46 | Epirubicin | Solution for injection containing epirubicin hydrochloride 200 mg in 100 mL | Injection/Intravesical | Epirubicin Accord | 36.14 |
47 | Epirubicin | Solution for injection containing epirubicin hydrochloride 200 mg in 100 mL | Injection/Intravesical | Epirubicin ACT | 36.14 |
48 | Epirubicin | Solution for injection containing epirubicin hydrochloride 200 mg in 100 mL | Injection/Intravesical | Pharmorubicin | 36.14 |
49 | Epirubicin | Solution for injection containing epirubicin hydrochloride 50 mg in 25 mL | Injection/Intravesical | Epirube | 9.04 |
50 | Epirubicin | Solution for injection containing epirubicin hydrochloride 50 mg in 25 mL | Injection/Intravesical | Epirubicin ACT | 9.04 |
51 | Epirubicin | Solution for injection containing epirubicin hydrochloride 50 mg in 25 mL | Injection/Intravesical | Pharmorubicin | 9.04 |
[3] Schedule 1
omit:
99 | Ivabradine | Tablet 5 mg (as hydrochloride) | Oral | APO-Ivabradine | 27.32 |
100 | Ivabradine | Tablet 5 mg (as hydrochloride) | Oral | Coralan | 27.32 |
101 | Ivabradine | Tablet 7.5 mg (as hydrochloride) | Oral | APO-Ivabradine | 27.32 |
102 | Ivabradine | Tablet 7.5 mg (as hydrochloride) | Oral | Coralan | 27.32 |
[4] Schedule 1
omit:
113 | Pemetrexed | Powder for I.V. infusion 1 g (as disodium) | Injection | DBL Pemetrexed | 51.92 |
114 | Pemetrexed | Powder for I.V. infusion 1 g (as disodium) | Injection | Pemetrexed Accord | 51.92 |
115 | Pemetrexed | Powder for I.V. infusion 100 mg (as disodium) | Injection | Alimta | 5.19 |
116 | Pemetrexed | Powder for I.V. infusion 100 mg (as disodium) | Injection | DBL Pemetrexed | 5.19 |
117 | Pemetrexed | Powder for I.V. infusion 100 mg (as disodium) | Injection | Pemetrexed Accord | 5.19 |
118 | Pemetrexed | Powder for I.V. infusion 100 mg (as disodium) | Injection | PEMETREXED-DRLA | 5.19 |
119 | Pemetrexed | Powder for I.V. infusion 100 mg (as disodium) | Injection | Reladdin | 5.19 |
120 | Pemetrexed | Powder for I.V. infusion 100 mg (as disodium) | Injection | Tevatrexed | 5.19 |
121 | Pemetrexed | Powder for I.V. infusion 500 mg (as disodium) | Injection | Alimta | 25.96 |
122 | Pemetrexed | Powder for I.V. infusion 500 mg (as disodium) | Injection | DBL Pemetrexed | 25.96 |
123 | Pemetrexed | Powder for I.V. infusion 500 mg (as disodium) | Injection | Pemetrexed Accord | 25.96 |
124 | Pemetrexed | Powder for I.V. infusion 500 mg (as disodium) | Injection | Pemetrexed APOTEX | 25.96 |
125 | Pemetrexed | Powder for I.V. infusion 500 mg (as disodium) | Injection | Pemetrexed DRLA | 25.96 |
126 | Pemetrexed | Powder for I.V. infusion 500 mg (as disodium) | Injection | Reladdin | 25.96 |
127 | Pemetrexed | Powder for I.V. infusion 500 mg (as disodium) | Injection | Tevatrexed | 25.96 |
Schedule 2 Amendments
[5] Schedule 2
after:
485 | Bisoprolol | Tablet containing bisoprolol fumarate 5 mg | Oral | Terry White Chemists Bisoprolol | 6.49 |
insert:
485A | Bivalirudin | Powder for I.V. injection 250 mg (as trifluoroacetate) | Injection | Angiomax | 474.81 |
485B | Bivalirudin | Powder for I.V. injection 250 mg (as trifluoroacetate) | Injection | Bivalirudin APOTEX | 474.81 |
after:
1766 | Isosorbide mononitrate | Tablet 60 mg (sustained release) | Oral | Terry White Chemists Isosorbide Mononitrate | 3.29 |
insert:
1766A | Isotretinoin | Capsule 5 mg | Oral | Oratane | 11.01 |
[7] Schedule 2
after:
1785 | Itraconazole | Capsule 50 mg | Oral | Lozanoc | 101.95 |
insert:
1785A | Ivabradine | Tablet 5 mg (as hydrochloride) | Oral | APO-Ivabradine | 31.03 |
1785B | Ivabradine | Tablet 5 mg (as hydrochloride) | Oral | Coralan | 31.03 |
1785C | Ivabradine | Tablet 7.5 mg (as hydrochloride) | Oral | APO-Ivabradine | 31.03 |
1785D | Ivabradine | Tablet 7.5 mg (as hydrochloride) | Oral | Coralan | 31.03 |